BNET Industries
- Private
- US
Dow Jones Description
Invitrogen is committed to being the leading provider of novel fluorescent reagents and detection solutions that advance scientific and biomedical research worldwide. Supplying superior Molecular Probes products and services, together with striving for customer and employee satisfaction, will be the driving forces of our organization.
Senior Vice President
Ben BulkleyPeer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
News & Analysis
Filter by
health care and invitrogen corp. - All News and Analysis
Invitrogen to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq: IVGN) announced it will present at the Lehman Brothers Eleventh Annual Global Healthcare Conference on Wednesday, March 19th, at 3:45 p.m. Eastern Time at Loews Miami Beach Hotel in Miami, Florida. To hear a live webcast of the presentation, visit the investor relations page...
Invitrogen to Present at 26th Annual JP Morgan Healthcare Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) announced it will present at the 26th Annual JPMorgan Healthcare Conference on Tuesday, January 8, 2008 at 2:30 p.m. Pacific Time at the Westin St. Francis Hotel in San Francisco. To hear a live webcast of the presentation, visit the investor relations page on...
Invitrogen to Present at the Bear Stearns 20th Annual Healthcare Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today that David F. Hoffmeister, Sr. Vice President and Chief Financial Officer, will present at the Bear Stearns 20th Annual Healthcare Conference being held at the Grand Hyatt, Park Avenue at...
Invitrogen to Present at the Bank of America 2007 Health Care Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) announced today that Nicolas Barthelemy, Invitrogen's Senior Vice President, Cell Culture Systems, will present at Bank of America's 2007 Health Care Conference being held at the Four Seasons Hotel in Las Vegas, Nevada. The company will present on Wednesday, May 30th, 2007 at 9:30...
Invitrogen to Present at Lehman Brothers Tenth Annual Global Healthcare Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), announced today that David F. Hoffmeister, Invitrogen's Chief Financial Officer, will present at the Lehman Brothers Tenth Annual Global Healthcare Conference in Miami, Florida, on Tuesday, March 20th, 2007. Mr. Hoffmeister's presentation will be webcast live and after the conference on Invitrogen's website www.invitrogen.com...
Invitrogen to Present at 25th Annual JP Morgan Healthcare Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) announced it will present at the 25th Annual JPMorgan Healthcare Conference on Wednesday, January 10, 2007 at 2:30 p.m. Pacific Time at the Westin St. Francis Hotel in San Francisco. To hear a live webcast of the presentation, visit the investor relations page on...
Invitrogen to Present at Bank of America 2006 Health Care Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), announced today that Gregory T. Lucier, Invitrogen's Chairman and CEO, will present at the Bank of America 2006 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 17, 2006. Mr. Lucier's presentation will be webcast live and after the conference on Invitrogen's website...
Invitrogen to Present at Deutsche Bank 2006 Health Care Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), announced today that David F. Hoffmeister, Invitrogen's Chief Financial Officer, will present at the Deutsche Bank 2006 Health Care Conference in Boston, Massachusetts, on Wednesday, May 3, 2006. Mr. Hoffmeister's presentation will be webcast live and after the conference on Invitrogen's website www.invitrogen.com in...
Invitrogen to Present at Lehman Brothers Ninth Annual Global Healthcare Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) announced today that David F. Hoffmeister, Invitrogen's Chief Financial Officer, will present at the Lehman Brothers Ninth Annual Global Healthcare Conference in Miami, on Wednesday, March 8th, 2006. Mr. Hoffmeister's presentation will be webcast live and after the conference on Invitrogen's website www.invitrogen.com in...
Invitrogen to Present at the Banc of America Securities 2005 Health Care Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) announced today that Greg Lucier, Chairman and CEO, will present at Banc of America Securities Health Care Conference in Las Vegas, Nevada on Tuesday, May 17, 2005, 3:20 p.m. Pacific Time. Mr. Lucier will be commenting on general business matters and will be reaffirming...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Ben Bulkley | Senior Vice President |
| David U'Prichard | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Donald W Grimm | Board Member |
| Raymond V. Dittamore | Board of Directors |
| W. Ann Reynolds PhD | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Invitrogen Corporation | Senior Vice President | Current |
| UCSD-CONNECT | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Care Capital, LLC | Venture Partner | Current |
| Red Abbey, LLC | Senior Advisor and Venture Partner | Current |
| University of Glasgow | Honorary Professor | Current |
| Red Abbey, LLC | Advisor | Current |
| Northwestern University | Associate Professor | Current |
| Glasgow University | Honorary Professor | Current |
| Genematrix, Inc. | Board Director | Current |
| Exsar Corporation | Board Director | Current |
| Guilford Pharmaceuticals, Inc. | Director | Current |
| Invitrogen Corporation | Director | Current |
| Cyclacel Limited | Board of Directors | Current |
| GlaxoSmithKline Plc | President | Former |
| SmithKline Beecham Corporation | President of Research and Development | Former |
| Druid Consulting | President | Former |
| Apax Partners Ltd. | Venture Partner | Former |
| Northwestern University School of Medicine | Associate Professor of Pharmacology and Neurobiology | Former |
| Biotechnology Industry Organization | member | Former |
| GlaxoSmithKline Plc | Chairman of Research and Development | Former |
| SmithKline Beecham Corporation | Chairman of R&D | Former |
| Biotechnology Industry Organization | Board Member | Former |
| University of Kansas | Ph.D. in Pharmacology | Former |
| University of Kansas | MS | Former |
| University of Glasgow | B.Sc. in Pharmacology | Former |
| Organization | Position | Status |
|---|---|---|
| Oligoperfect | Founder, Chairman and President, Strategic Design | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Founder, Chairman and President, Strategic Design | Current |
| Resgen Inc. | Founder, Chairman and President, Strategic Design | Current |
| Emiliem, Inc. | Founder, Chairman and President, Strategic Design | Current |
| Hamilton BioVentures | President | Current |
| Molecular Probes | Founder, Chairman and President, Strategic Design | Current |
| Biolayer Corporation Limited | Founder, Chairman and President, Strategic Design | Current |
| Strategic Design | President | Current |
| IDEXX Laboratories, Inc. | Founder, Chairman and President, Strategic Design | Current |
| Seqanswers | Founder, Chairman and President, Strategic Design | Current |
| Microseq | Founder, Chairman and President, Strategic Design | Current |
| Industry Ventures | Founder, Chairman and President, Strategic Design | Current |
| Olink | Founder, Chairman and President, Strategic Design | Current |
| Ionsource, LLC | Founder, Chairman and President, Strategic Design | Current |
| Bioreliance Corporation | Founder, Chairman and President | Current |
| Aegis Therapeutics, LLC | Executive Chairman | Current |
| Strategic Design | Chairman | Current |
| San Diego Regional Chamber of Commerce | Vice Chair | Current |
| Cellzdirect, Inc. | Board of Directors | Current |
| High Throughput Genomics, Inc. | Board of Directors | Current |
| Hamilton BioVentures | Director | Current |
| Intec Telecommunications | Board Member | Current |
| Invitrogen Corporation | Board Member | Current |
| University of Pittsburgh School of Pharmacy | Board Member | Current |
| Angstrom Pharmaceuticals, Inc. | Board of Directors | Current |
| Multiple Peptide Systems Inc | Board of Directors | Current |
| Scripps Clinic | Board Member | Current |
| Hybritech, Inc. | CEO | Former |
| Dura Pharmaceuticals, Inc. | Chief Executive Officer | Former |
| Biosource International, Inc. | Founder, Chairman and President, Strategic Design | Former |
| Hybritech, Inc. | President | Former |
| Copenhagen Capacity | Managing Director | Former |
| Hybritech, Inc. | Director of West Coast Pharmaceutical Sales | Former |
| Eli Lilly and Company | Director of Pharmaceutical Market Research | Former |
| Eli Lilly and Company | management positions | Former |
| U.S. Army | Officer | Former |
| Xcel Pharmaceuticals, Inc. | Former | |
| Verus Pharmaceuticals | Former | |
| Cadence Pharmaceuticals, Inc. | Former | |
| Hybritech, Inc. | Chairman | Former |
| Hybritech | Chairman | Former |
| Biovail Corporation | Chairman | Former |
| Pharmaceutical Market Research | Director | Former |
| Roundtable Inc. | Board of Directors | Former |
| Bioreliance Corporation | Director | Former |
| Somaxon Pharmaceuticals, Inc. | Board of Directors | Former |
| California Healthcare Institute, Inc. | Board of Directors | Former |
| University of Pittsburgh | M.B.A. | Former |
| Pittsburgh Tissue Engineering Initiative, Inc | M.B.A. | Former |
| Baldwin-Wallace College | Master's Degree In Business Administration | Former |
| Pittsburgh Tissue Engineering Initiative, Inc | B.S. In Pharmacy | Former |
| University of Pittsburgh | B.S. In Pharmacy | Former |
Raymond V. Dittamore has served as a Director of the Company since December 2002. Mr. Dittamore is a retired audit partner of Ernst & Young LLP, an international accounting firm. Mr. Dittamore retired in 2001 after 35 years of service with that firm, including 14 years as the managing partner of the firms San Diego office. Mr. Dittamore is also a director of Invitrogen Corporation, Gen-Probe Incorporated, and Digirad Corporation. Mr. Dittamore received a B.S. degree from San Diego State University.
| Organization | Position | Status |
|---|---|---|
| QUALCOMM Incorporated | Board of Directors | Current |
| Molecular Probes | Director | Current |
| Invitrogen Corporation | Board of Directors | Current |
| IDEXX Laboratories, Inc. | Board of Directors | Current |
| Biolayer Corporation Limited | Director | Current |
| Ionsource, LLC | Board of Directors | Current |
| Microseq | Board of Directors | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Board of Directors | Current |
| Industry Ventures | Board of Directors | Current |
| Gen-Probe Inc. | Board of Directors | Current |
| Applied Molecular Evolution, Inc. | Director | Current |
| Ernst & Young | partner | Former |
| Ernst & Young | collaborative editor | Former |
| Digirad Corporation | Board of Directors | Former |
| San Diego State University | B.S. | Former |
| QUALCOMM Incorporated | member | Former |
W. Ann Reynolds, 71, formerly President and Professor of Biology at The University of Alabama at Birmingham, located in Birmingham, Alabama, until 2002. Director since 2006; formerly a Director of OCD since 1993. A graduate of Kansas State Teachers College and the University of Iowa, where she earned a Ph.D. degree, Dr. Reynolds previously served as Chancellor of the City University of New York and as Chancellor of the California State University System. In prior years, she was Provost of the Ohio State University and Professor of Anatomy and Vice Chancellor for Research at the University of Illinois at the Medical Center. Dr. Reynolds is a director of Humana, Inc., Abbott Laboratories, Invitrogen Corporation, and the News-Gazette, Champaign, Illinois.
| Organization | Position | Status |
|---|---|---|
| News Gazette Inc. | Director | Current |
| Humana Inc. | Board of Directors | Current |
| Abbott Laboratories | Board of Directors | Current |
| Owens Corning | Board of Directors | Current |
| Industry Ventures | Board of Directors | Current |
| Business-Higher Education Forum | Member of The Board of The Champaign, Urbana News Gazette | Current |
| Olink | Board of Directors | Current |
| KMG America Corporation | Member of The Board of The Champaign, Urbana News Gazette | Current |
| IDEXX Laboratories, Inc. | Board of Directors | Current |
| Resgen Inc. | Board of Directors | Current |
| Maytag Corporation | Board of Directors | Current |
| Ionsource, LLC | Board of Directors | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Board of Directors | Current |
| Microseq | Board of Directors | Current |
| Abms Member | Board of Directors | Current |
| Invitrogen Corporation | Board of Directors | Current |
| The University of Alabama at Birmingham | President | Former |
| University of Illinois | Professor | Former |
| University of Illinois College of Medicine | Research Professor | Former |
| Emporia State University | M.S. | Former |
| Emporia State University | Bachelors Degree In Biology | Former |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes

